ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,886.00
0.20%
다우존스 지수
40,211.72
0.00%
Bitcoin
63,792.69
-1.63%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VNDA
일자시간출처헤드라인심볼기업
2018/06/1405:09Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/06/1405:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/06/0205:48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/06/0205:30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/06/0201:00PR Newswire (US)Vanda Pharmaceuticals Announces Participation at June 2018 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/05/2405:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/05/2321:00PR Newswire (US)HETLIOZ® (tasimelteon) Effective in Treating Jet Lag during Transatlantic TravelNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/05/0722:00PR Newswire (US)Vanda Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/05/0505:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/05/0306:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/05/0305:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/05/0305:01PR Newswire (US)Vanda Pharmaceuticals Reports First Quarter 2018 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/04/2720:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/04/2720:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/04/2606:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/04/2406:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/04/1905:30PR Newswire (US)Vanda Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 2, 2018NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/04/1405:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/04/1401:00PR Newswire (US)Vanda Wins Appeal Case on Fanapt®NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/04/1005:01PR Newswire (US)Vanda to Present Tradipitant Scientific Posters at the 10th Georg Rajka International Symposium of Atopic DermatitisNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/2620:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/2106:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/1705:36Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/1619:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/1608:46PR Newswire (US)Vanda Pharmaceuticals Inc. Prices Public Offering of Common StockNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/1505:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/1505:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/1505:01PR Newswire (US)Vanda Pharmaceuticals Inc. Proposes Public Offering of Common StockNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/0706:30PR Newswire (US)Vanda Pharmaceuticals Announces Participation at March 2018 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2018/03/0521:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:VNDA

최근 히스토리

NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
AMEX
XLV
Health Care Select Sector
PM
XAUUSD
Gold vs US Dollar
FX
USDGBP
US Dollar vs Sterling
USOTC
BASFY
BASF (QX)
NYSE
XOM
Exxon Mobil
COIN
ETHUSD
Ethereum
USI
USTECH100
US Tech 100
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
NYSE
AXP
American Express
NYSE
MRK
Merck
CCOM
US500
US 500
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유